Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase.

No abstract is available for this paper.

• Publication year

  1971

• Venue

  Surgery

• Publication date

  1971-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.5555/URI:PII:0039606071900870PMID 5092115
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of neuraminidase on serological properties of murine lymphoid cells.

  1971cited by this paper
• ANTIGENIC SPECIFICITIES ON MURINE SARCOMA CELLS

  1971cited by this paper
• Mechanism of neuraminidase induced antigen "unmasking".

  1970cited by this paper
• The mechanism of increased sensitivity of neuraminidase treated cells to antibody induced cytolysis. Abstr.

  1970cited by this paper
• Immunological Factors in Human Sarcomas and Melanomas: A Rational Basis for Immunotherapy

  1970cited by this paper
• Immunological factors affecting tumour growth.

  1970cited by this paper
• Tumour specific immunogenicity of methylcholanthrene-induced sarcoma cells after incubation in neuraminidase.

  1969cited by this paper
• Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.

  1969cited by this paper
• THE EFFECT OF NEURAMINIDASE ON THE FATE OF TRANSFUSED LYMPHOCYTES

  1969cited by this paper
• Immunogenicity of L 1210 Murine Leukaemia Cells after Treatment with Neuraminidase

  1968cited by this paper
• The role of sialic acid in antigenic expression: further studies of the Landschütz ascites tumour.

  1968cited by this paper
• Effect of Neuraminidase on the Phagocytosis of Heterologous Red Cells by Mouse Peritoneal Macrophages

  1968cited by this paper
• Passive serologic transfer of allograft immunity in immunologically suppressed mice. I. Immunosuppression by heterologous anti-lymphocyte serum.

  1967cited by this paper
• AN ALTERATION IN TUMOR HISTOCOMPATIBILITY INDUCED BY NEURAMINIDASE

  1967cited by this paper
• Sialic Acid Binding Sites: Role in Hemagglutination by Mycoplasma gallisepticum

  1966cited by this paper
• Tumor antigens.

  1966cited by this paper
• STUDIES ON CELL DEFORMABILITY

  1965cited by this paper

• The Effect of Corynebacterium parvum and other Reticuloendothelial Stimulants on Transplanted Tumours in Mice

  2008cites this paper
• future controlled clinical trials of immunotherapy. Tumor Regression and Enhancement Resulting from Immunotherapy with Bacillus Calmette-Guérin and Neuraminidase'

  2006cites this paper
• Characterization and Use of Neuraminidase-modified L1210 Plasma Membranes for Protection against Tumor Growth1

  2004cites this paper
• Comparative immunogenicity of irradiated, neuraminidase treated, and fused cells of a strain-restricted sarcoma

  2004cites this paper
• Tumor therapy of neoplastic diseases with tumor cells and neuraminidase

  2004cites this paper
• Immunotherapy and Immunopotentiation

  1993cites this paper
• Immunotherapy with bacterial endotoxins.

  1990cites this paper
• Vaccine Immunotherapy of Melanoma

  1990cites this paper
• Release of protein bound sialic acid from fibrosarcoma cells after cis-dichlorodiammine platinum (II) treatment: the possible role in tumor regression.

  1988cites this paper
• Search for antitumor agents among synthetic polycations (survey)

  1988cites this paper
• Immunogenicity of a polyvalent melanoma antigen vaccine in humans

  1988cites this paper
• [Enzyme therapy of tumors].

  1987cites this paper
• Immunology and oncology.

  1985cites this paper
• Immunostimulation: synthetic and biological modulators of immunity.

  1984cites this paper
• Metastasis control by injection of blood lymphocytes cultured with neuraminidase-treated MT/W 449A rat mammary carcinoma.

  1984cites this paper
• Experimental models in cancer immunotherapy.

  1984cites this paper
• Cell surface glycolipids and glycoproteins in malignant transformation.

  1983cites this paper
• Modulation of the recognition and lysis of EL4 tumor target cells by cytotoxic T lymphocytes.

  1982cites this paper
• Manganese potentiation of autologous anti-meth a tumor vaccines

  1982cites this paper
• Biological Significance of Sialic Acids

  1982cites this paper
• Importance of antigen-lymphocyte interaction in establishment of cellular immunity.

  1981cites this paper
• Characterization and use of neuraminidase-modified L1210 plasma membranes for protection against tumor growth.

  1981cites this paper
• Immunotherapy of L1210 leukemia using neuraminidase-modified plasma membranes combined with chemotherapy.

  1981cites this paper
• Micro-necrotic foci in regression of a murine calvarium transplantable tumor. 3. Histological characteristics of the micro-necrotic foci.

  1980cites this paper
• Transitional mucosa and survival in human colorectal cancer

  1980cites this paper
• The presence of anti-leukoblast antibodies as complement fixation agents in leukemia patients imm-nized with leukoblats treated with neuraminidase and radiation.

  1980cites this paper
• Serum sialic acid and CEA concentrations in human breast cancer.

  1980cites this paper
• Surface Glycolipid and Glycoprotein Antigens

  1980cites this paper
• Immunity and drug resistance in a mouse glioma

  1980cites this paper
• Effect of Vibrio cholerae neuraminidase on the mitogen response of T lymphocytes. I. Enhancement of macrophage T-lymphocyte cooperation in concanavalin-A-induced lymphocyte activation.

  1980cites this paper
• ULTRASTRUCTURAL DEMONSTRATION OF THE NEGATIVE SURFACE CHARGE ON HUMAN TROPHOBLAST

  1980cites this paper
• Micro-necrotic foci in regression of a murine calvarium transplantable tumor. 2. Enzymatic modification of the transformed calvarium cell immunological characteristics.

  1980cites this paper
• Effect of Vibrio cholerae neuraminidase on the mitogen response of T-lymphocytes. II. Modulation of the lymphocyte response to macrophage released factors by neuraminidase.

  1980cites this paper
• Immunotherapy models in experimental animals.

  1979cites this paper
• Accessibility of sialo components in a murine tumor cell to extracellular N-acetylneuraminate glycohydrolase (sialidase).

  1979cites this paper
• Influence of neuraminidase and mitomycin C on the immunogenicity of Novikoff tumor cells

  1979cites this paper
• Immunotherapy of spontaneous mammary tumors in mongrel dogs with autologous tumor cells and neuraminidase

  1979cites this paper
• Effect of local immunotherapy of syngeneic rat fibrosarcoma with hapten and antihapten-tumor serum upon nonlocally treated tumor.

  1979cites this paper
• Inhibition of growth of rat Yoshida sarcoma using a neuraminidase treated tumour vaccine.

  1979cites this paper
• Adjuvant immunotherapy of malignant melanoma

  1979cites this paper
• Chemoimmunotherapy of stage III breast carcinoma with BCG and a live allogeneic tumor cell vaccine

  1979cites this paper
• Immunotherapy of neoplastic diseases with neuraminidase: Contradictions, new aspects, and revised concepts

  1978cites this paper
• Modification of the immunologic properties of the cell surface.

  1978cites this paper
• Streptococcus faecalis organisms inhibit tumour growth.

  1978cites this paper
• Bullous pemphigoid and ovarian cystadenocarcinoma. Immunologic studies.

  1978cites this paper
• Immune Response in Cancer Patients

  1978cites this paper
• Neuraminidase effect on the growth of a transplantable nickel sulfide-induced rat tumor.

  1978cites this paper
• Fc receptor-bearing lymphoid cells in the chicken. I. Characterization of the Fc(IgG) receptor.

  1978cites this paper
• Failure of immunotherapy with neuraminidase-treated tumor cell vaccine in mice bearing established 3-methylcholanthrene-induced sarcomas.

  1978cites this paper
• Experimental specific immunotherapy

  1978cites this paper
• Cell-mediated cytotoxicity and serum-mediated blocking: evidence that their associated determinants on human tumor cells are different.

  1978cites this paper
• Modifications of lectin binding on human leukemic cells after neuraminidase treatment.

  1978cites this paper
• The modification of the growth characteristics of the Landschütz ascites tumour by neuraminidase.

  1978cites this paper
• Effectiveness of neuraminidase in experimental immunotherapy of two murine pulmonary carcinomas.

  1977cites this paper
• Effectivenessof Neuraminidasein ExperimentalImmunotherapy of Two Murine PulmonaryCarcinomas

  1977cites this paper
• Prolonged inhibition of protein and glycoprotein synthesis in tumor cells treated with muconomycin A.

  1977cites this paper
• The immunotherapeutic value of a L1210 tumor cell vaccine depends upon the expression of cell-surface carbohydrates

  1977cites this paper
• Neuraminidase and tumor immunotherapy

  1977cites this paper
• Immunotherapeutic use of neuraminidase in chemically induced carcinogenesis

  1977cites this paper
• VCN-releasable sialic acid and gangliosides in human neuroblastomas.

  1977cites this paper
• Bacterial neuraminidase and altered immunological behavior of treated mammalian cells.

  1977cites this paper
• Preparation of fixed antigenic, non-oncogenic and protective neoplastic cells

  1977cites this paper
• Antigenicity of a Spontaneous Murine Mammary Adenocarcinoma during in Vitro Cultivation

  1977cites this paper
• [Serum levels of N-acetyl-neuraminic acid in normal subjects and patients with gastric cancer and gastric ulcer (author's transl)].

  1977cites this paper
• Antigenic differences among osteogenic sarcoma tumor cells taken from different locations in human tumors.

  1977cites this paper
• The combined effect of radiotherapy and neuraminidase‐treated tumor cells on 3‐methylcholanthrene‐induced fibrosarcoma

  1977cites this paper
• Specific cytotoxic antibody in the sera of patients with melanoma.

  1976cites this paper
• Immunological control of virus-associated tumors in man: a perspective.

  1976cites this paper
• ACTIVE SPECIFIC IMMUNOTHERAPY OF HUMAN SOLID TUMORS

  1976cites this paper
• Humoral reactions in syngeneic hosts against tumor cell surface incomplete saccharide moieties

  1976cites this paper
• Correlations between humoral immunity and successful chemotherapy-immunotherapy.

  1976cites this paper
• Modified tumor cells in the immunotherapy of solid mammary tumors.

  1976cites this paper
• Biological Basis:Tumour Associated Antigens, the Immune Machinery, and Its Behaviour Concerning Cancer Cells

  1976cites this paper
• Neuraminidase immunotherapy: Serum potentiation of lymphocyte cytotoxicity related to immunoglobulin levels

  1976cites this paper
• Immunotherapy with neuraminidase-treated cells and bacillus Calmette-Guerin.

  1976cites this paper
• The Biological Role of Sialic Acid at the Surface of the Cell

  1976cites this paper
• Effect of syngeneic sensitized lymphoid cells on incidence and growth of methyl cholanthrene-induced and spontaneous tumors in mice.

  1976cites this paper
• Antitumor immunity. II. Viability, tumorigenicity, and immunogenicity of neuraminidase-treated tumor cells: effective immunization of animals with a tumor vaccine.

  1976cites this paper
• Humoral reponse to neuraminidase-treated tumor cells.

  1976cites this paper
• EXPERIMENTAL CANCER IMMUNOTHERAPY: MODIFICATION OF TUMOR CELLS TO INCREASE IMMUNOGENICITY *

  1976cites this paper
• Effect of Vibrio cholerae neuraminidase on the generation of cell-mediated cytotoxicity in vitro.

  1976cites this paper
• Immunotherapy and chemotherapy in children with neuroblastoma.

  1976cites this paper
• OF AUTOCHTHONOUS TUMOR CELLS IN CANINE LYMPHOMA

  1976cites this paper
• Application of transfer factor to clinical immunotherapy.

  1976cites this paper
• Active immunotherapy of L1210 leukemia with neuraminidase-treated, drug-resistant L1210 sublines

  1976cites this paper
• [Antitumoral immunity induced by the administration of homologous and isologous tumoral cells treated by moderate heating].

  1976cites this paper
• Increase in cell surface antigen expression by leukemic cells following in vitro treatment with papain.

  1976cites this paper
• Characteristics of immunity induced by neuraminidase-treated lymphosarcoma cells in C3H (MTV+) and C3H (MTV-) mice.

  1976cites this paper
• Immuno-therapy of methyl cholanthrene induced and spontaneous tumors in mice by use of tumor vaccine, neuraminidase and BCG.

  1976cites this paper
• Intralymphatic infusion of autochthonous tumor cells in canine lymphoma.

  1976cites this paper
• Antitumor Immune Response Following Injection of Neuraminidase‐treated Sarcoma Cells

  1975cites this paper
• Letter: Immunotherapy inaccuracy.

  1975cites this paper
• Comparative immunotherapeutic effect of concanavalin A and neuraminidase-treated cancer cells.

  1975cites this paper
• Enzymes as therapeutic agents.

  1975cites this paper
• Antitumour immunity--1. Differential response of neuraminidase-treated and x-irradiated tumour vaccine.

  1975cites this paper
• Modifying the immunogenicity of cell membrane antigens. Tumors and transplants.

  1975cites this paper
• Future prospects for immunotherapy

  1975cites this paper
• Prospects for the immunotherapy of cancer. Part I: Basic concepts of tumor immunology.

  1975cites this paper
• Immunotherapy with neuraminidase-treated tumor cells after radiotherapy.

  1975cites this paper
• Immunologic approach to cancer therapy.

  1975cites this paper